INmune Bio financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

인뮨 바이오NASDAQ:INMB · Nasdaq · Healthcare

$1.94+0.52%

2026-10-05 close

INmune Bio's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$43M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy